Smart Money Is Betting Big In MRK Options
Smart Money Is Betting Big In MRK Options
Financial giants have made a conspicuous bearish move on Merck & Co. Our analysis of options history for Merck & Co (NYSE:MRK) revealed 9 unusual trades.
默沙东遭遇金融巨头明显看淡，我们对默沙东（NYSE:MRK）期权历史的分析发现了9笔飞凡交易。
Delving into the details, we found 44% of traders were bullish, while 55% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $123,625, and 6 were calls, valued at $299,194.
详细了解后，我们发现44%的交易者看涨，而55%的交易行为呈现看淡趋势。在我们发现交易中，3笔为看跌期权，价值$123,625，6笔为看涨期权，价值$299,194。
Projected Price Targets
预计价格目标
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $120.0 to $130.0 for Merck & Co during the past quarter.
在这些合约中分析成交量和持仓量，似乎大型交易者在过去一季度眼中盯着默沙东在$120.0至$130.0的价位区间。
Analyzing Volume & Open Interest
分析成交量和未平仓合约
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Merck & Co's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Merck & Co's substantial trades, within a strike price spectrum from $120.0 to $130.0 over the preceding 30 days.
评估成交量和持仓量是期权交易中的一个战略性步骤。这些指标阐明了在特定行权价的情况下，投资者在默沙东期权上的流动性和兴趣。即将发布的数据将展示在先前30天内默沙东在$120.0至$130.0的行权价范围内，与看涨看跌期权相联系的成交量和持仓量的波动。
Merck & Co Call and Put Volume: 30-Day Overview
默沙东的看涨和看跌成交量：30天概述
Significant Options Trades Detected:
检测到重大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRK | CALL | SWEEP | BULLISH | 07/26/24 | $3.9 | $3.7 | $3.85 | $124.00 | $73.5K | 443 | 214 |
| MRK | CALL | SWEEP | BEARISH | 08/02/24 | $3.1 | $3.0 | $3.0 | $127.00 | $60.0K | 300 | 226 |
| MRK | CALL | SWEEP | BULLISH | 09/20/24 | $9.7 | $9.7 | $9.7 | $120.00 | $55.2K | 1.9K | 60 |
| MRK | PUT | TRADE | BULLISH | 07/26/24 | $0.43 | $0.33 | $0.35 | $125.00 | $51.9K | 1.6K | 4.0K |
| MRK | CALL | SWEEP | BEARISH | 08/02/24 | $3.05 | $3.0 | $3.05 | $127.00 | $45.7K | 300 | 193 |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRK | 看涨 | SWEEP | 看好 | 07/26/24 | $3.9 | $3.7 | $3.85 | $124.00 | $73.5K | 443 | 214 |
| MRK | 看涨 | SWEEP | 看淡 | 08/02/24 | $3.1 | $3.0 | $3.0 | $127.00 | $60.0K | 300 | 226 |
| MRK | 看涨 | SWEEP | 看好 | 09/20/24 | 9.7 | 9.7 | 9.7 | $120.00 | $55.2K | 1.9K | 60 |
| MRK | 看跌 | 交易 | 看好 | 07/26/24 | $0.43 | $0.33 | $0.35 | $125.00 | $51.9K | 1.6K | 4.0K |
| MRK | 看涨 | SWEEP | 看淡 | 08/02/24 | $3.05 | $3.0 | $3.05 | $127.00 | 45700美元 | 300 | 193 |
About Merck & Co
关于默沙东
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
默沙东生产多种药品，治疗多种领域的疾病，包括心代谢症、癌症和感染。在癌症领域，该公司的免疫肿瘤学平台正在成为总销售额的主要贡献者。该公司还具有实质性的疫苗业务，包括预防儿童疾病以及人类乳头瘤病毒（HPV）治疗。此外，默沙东出售与动物健康相关的药品。从地理角度来看，公司销售额的近一半来自于美国境内。
After a thorough review of the options trading surrounding Merck & Co, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
对于默沙东周围的期权交易进行全面审查后，我们开始更详细地审查该公司的情况。这包括对其当前市场地位和表现的评估。
Present Market Standing of Merck & Co
默沙东的现市场地位
- Trading volume stands at 4,941,230, with MRK's price up by 0.4%, positioned at $126.42.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 5 days.
- 交易量为4,941,230，MRK的价格上涨了0.4%，位于$126.42。
- RSI指标显示该股票目前处于超买和超卖之间的中立状态。
- 预计5天内将公布业绩报告。
What The Experts Say On Merck & Co
默沙东公司专家们的观点
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $134.0.
过去30天中，共有1位专业分析师对这只股票进行了评估，并设定了一个平均价格目标为$134.0。
- An analyst from Morgan Stanley has decided to maintain their Equal-Weight rating on Merck & Co, which currently sits at a price target of $134.
- 大摩资源lof的一位分析师决定维持对默沙东的等权重评级，当前价格目标为$134。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Merck & Co with Benzinga Pro for real-time alerts.
期权交易涉及更大的风险，但也提供了更高的利润潜力。精明的交易者通过持续教育、战略性交易调整、利用各种因子和关注市场动态来降低这些风险。使用 Benzinga Pro 获取默沙东的最新期权交易实时警报。